Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1057

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 85509-1057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (10574)

This text appears to be a package insert for Ondansetron Tablets, USP containing 4 mg of ondansetron hydrochloride per film-coated tablet. The usual dosage instructions are not provided in the text, but it advises scanning the QR code on the package insert for detailed Dosage and Administration information. The tablets should be stored between 20°C to 25°C, with excursions permitted between 15°C to 30°C, and protected from light. The product is manufactured by Aurobindo Pharma Limited and repackaged by PHOENIX RX LLC. It also includes the NDC number, expiration date, and other relevant details for identification and tracking.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.